Related Experiment Video

Updated: Aug 9, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

More on human immunodeficiency virus embryopathy

S Iosub1, M Bamji, R K Stone

  • 1Department of Pediatrics, Metropolitan Hospital Center, New York, NY 10029.

Pediatrics
|October 1, 1987
PubMed

Insights

Human immunodeficiency virus embryopathy, a condition in infants with HIV/AIDS, presents with growth failure and distinct facial features. These dysmorphic characteristics are crucial for early identification and understanding the impact of HIV on development.

Area of Science:

  • Pediatric Medicine
  • Infectious Diseases
  • Clinical Genetics

Background:

  • Acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC) affect infants and young children.
  • Emerging evidence suggests a pattern of dysmorphic features associated with prenatal exposure to human immunodeficiency virus (HIV).

Purpose of the Study:

  • To evaluate the presence and significance of dysmorphic features in infants diagnosed with HIV/AIDS or ARC.
  • To describe the specific facial characteristics associated with human immunodeficiency virus embryopathy.

Main Methods:

  • Retrospective evaluation of eight pediatric patients (4-33 months) with HIV/AIDS or ARC.
  • Analysis of available birth data and growth charts.
  • Clinical assessment for specific dysmorphic features.

Main Results:

  • Majority of patients exhibited growth failure.
  • Common dysmorphic features included a prominent box-like head, large wide eyes, and a well-formed philtrum.
  • Other observed features included hypertelorism, oblique palpebral fissures, blue scleras, a depressed nasal bridge, and a prominent upper vermilion border.

Conclusions:

  • The described dysmorphic features are significant indicators of human immunodeficiency virus embryopathy in infants with HIV.
  • Recognition of these features can aid in early diagnosis and management of HIV-exposed and infected children.
  • Further research is warranted to understand the full spectrum and implications of these findings.

More Related Videos

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...